Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2008
Date:4/21/2008

or excluding each

of these individual items:

-- Acquisition-related charges -- These adjustments primarily consist of

purchased research and development, integration costs associated with

the Company's acquisition of Guidant, and a fair value adjustment

related to the sharing of proceeds feature of the Abbott stock

purchase. Purchased research and development is a highly variable

charge based on valuation assumptions. Management removes the impact of

purchased research and development from the Company's operating results

to assist in assessing the Company's operating performance and cash

generated from operations. The integration costs associated with the

Company's acquisition of Guidant do not reflect expected on-going

future operating expenses. The fair value adjustment related to the

sharing of proceeds feature of the Abbott stock purchase is a non-cash

adjustment and is not indicative of the Company's on-going operations.

Accordingly, management excluded these charges for purposes of

calculating these non-GAAP measures to facilitate an evaluation of the

Company's current operating performance and a comparison to the

Company's past operating performance.

-- Gain on divestitures -- These gains are not indicative of future

operating performance and are not used by management to assess

operating performance. Accordingly, management excluded these amounts

for purposes of calculating these non-GAAP measures to facilitate an

evaluation of the Company's current operating performance and a

comparison to the Company's past operating performance.

-- Restructuring-related charges -- These adjustments primarily represent

employee-related termination benefits, asset write-downs and other

costs associated with the Company's restructuring initiati
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013  Continuing its long history ... (MI), Beckman Coulter , Inc. announces the U.S. ... new Access AccuTnI+3 troponin I assay for use on ... have depended on Beckman Coulter,s troponin I ... assay has the proven performance to continue providing dependability ...
(Date:6/19/2013)... Today DuPont Executive Vice President James ... in the greatest challenge facing our time – ensuring ... Borel spoke at the International Food and Agribusiness ... need for students to contribute their time and talents ... reached in collaboration with others. , “Food is one ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 BioConvergence ... the speaking faculty at 2013’s BioLogistics Summit in ... conference, coordinated by Cold Chain IQ and IQPC, ... This “complexity” is, in part, attributed to current ... , “Implicit within these trends is an increase ...
(Date:6/19/2013)... (PRWEB) June 18, 2013 A new ... materials, costs and other trends will highlight technical sessions ... California this fall. In its 33rd year, the three-day ... an exhibition of key suppliers, approximately 100 technical presentations ... SPIE, the international society for optics and photonics , ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
... 2 GlaxoSmithKline plc (GSK),announced today that Fountain ... a cash tender offer to purchase all,outstanding shares ... SIRT ) (Sirtris), for $22.50 in cash without ... offer is being made pursuant to a,previously announced ...
... P3(TM) Technology Raising the Bar in Motion Preservation, ... Technology,Inc., a leader in innovative medical devices, announced ... cervical total disc,replacement (TDR), NuNec Cervical Arthroplasty Device. ... Zou and Wenwen Wu in Beijing China, on,patients ...
... to $11.7 million, -- Quarterly Net Income Increases ... NEW YORK and HAIKOU, Hainan, China, May ... (OTC Bulletin Board: CPHI),which develops, manufactures, and markets ... its financial results,for the first quarter of 2008., ...
Cached Biology Technology:GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 2GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals 3Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device 2China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 2China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 3China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 4China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 5China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 6China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 7China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 8China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results 9
(Date:6/19/2013)... The Microbial Diversity Course at the Marine Biological ... a Milestones in Microbiology site by the American ... in Microbiology program recognizes institutions and the scientists ... toward advancing the science of microbiology. A ... site is scheduled for Saturday, June 22, 2013, ...
(Date:6/19/2013)... June 19, 2013 AT&T * ... upcoming launch of the ultimate workhorse among ruggedized ... As one of the most ruggedized phones equipped ... Terrain embodies toughened versatility and business-ready features.  Its ... keep workforces moving forward, while also keeping up ...
(Date:6/19/2013)... A new variety of canary seeds bred specifically for ... be ideal for people with celiac disease (CD), scientists ... Journal of Agricultural and Food Chemistry . , ... least 3 million people in the United States alone ... eating wheat, barley, rye and other grains that contain ...
Breaking Biology News(10 mins):Microbial diversity course designated as a 'Milestones in Microbiology' site 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5
... across Europe are embarking on new research to develop a ... million EU citizens and there is no cure," says Dr ... partner in the Food Allergy Specific Therapy (FAST) research project. ... foods to which they are allergic. The threat of severe ...
... Biology are pleased to announce that Dr Audrey ... of this year,s JEB Outstanding Paper Prize. The award ... Journal of Experimental Biology at http://jeb.biologists.org ., ... young scientist to an exceptional research paper. Dussutour was ...
... environmental threat has been detected in North American ... Along with scientists from several Canadian government ... by declining levels of calcium in many temperate, ... Queen,s PhD candidate Adam Jeziorski, lead author of ...
Cached Biology News:Scientists developing food allergy treatment 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 3Queen's University biologists find new environmental threat in North American lakes 2
... Epithelial and endothelial cells-directed ... a RGD peptide-conjugated polyethylenimine which ... integrin-expressing epithelial and endothelial cells. ... in cell-cell and cell-matrix adhesion ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Request Info...
... Accurate To score SNPs, ... sequencing, the gold standard in DNA analysis. ... The polymorphic locus can be confirmed by ... DNA sequencing also provides sequence context information, ...
Biology Products: